Mr Doru Gavril > Freshfields Bruckhaus Deringer LLP > Silicon Valley, United States > Lawyer Profile

Freshfields Bruckhaus Deringer LLP
2710 Sand Hill Road
Menlo Park
California, 94025
CALIFORNIA
United States

Work Department

Litigation

Position

Partner

Career

Doru Gavril represents public companies and their officers and directors in shareholder litigation, government and internal investigations, and advises on corporate governance matters.

Doru’s practice involves complex, multi-forum litigation across the entire range of shareholder disputes: securities class actions, derivative actions, shareholder class actions, deal litigation and books and records actions. Doru has had extensive experience litigating cutting edge issues in the securities field, such as concurrent federal and state jurisdiction over Securities Act actions, forum selection provisions in foundational corporate documents, the applicability of materially adverse change clauses and disputed tender offers.

Before joining Freshfields, Doru worked at Wilson Sonsini Goodrich & Rosati. Prior to that, Doru served as a judicial extern in the chambers of the Honorable Marilyn Hall Patel of the United States District Court for the Northern District of California. During his graduate studies, Doru was a teaching fellow at Harvard University, where he taught sections of courses on the presidency, Congress and introductory economics. He also served as a legislative intern for Senator Carl Levin of Michigan and Representative Robert A. Brady of Pennsylvania.

Education

  • J.D., Stanford Law School
    Recipient, Class of 1959 Silver Anniversary Scholarship and John Hart Ely Prize for empirical research of jury trials
  • M.A., Political Science, Harvard Graduate School of Arts and Sciences
  • B.A., Political Science and Economics, Swarthmore College
    With High Honors; Recipient, Laurama Page Pixton Scholarship and J. Roland Pennock Fellowship in Public Affairs

Lawyer Rankings

United States > Dispute resolution > M&A litigation: defense

Freshfields Bruckhaus Deringer LLP‘s M&A litigation practice is one of the bright spots for English firms in the US litigation market. Thanks to standout partners and practice heads Meredith Kotler and Mary Eaton, the firm is able to handle market-leading matters for stellar corporate clients, among them Tesla, Google and Pinterest. For AstraZeneca, Kotler and Eaton are involved in matters in Delaware concerning challenges to the sale of spinoff company Viela Bio to Horizon. The case raises important issues of what constitutes a control by a major shareholder. Head of the US technology practice Boris Feldman, who works from the Silicon Valley office, has defended more than 250 shareholder class actions, derivative suits, and merger challenges during his long career, and he frequently works with up-and-coming partner Doru Gavril to handle shareholder inspection demands and major class actions against Tesla and its board of directors. Counsel Nicholas Caselli is an emerging talent whose work in securities and shareholder litigation includes class actions, derivative actions, section 220 books and records demands, and deal-related matters.

United States > Dispute resolution > Securities litigation: defense

The New York office of Freshfields Bruckhaus Deringer LLP continues to make big strides in the securities litigation arena, having built a high-calibre practice around highly regarded practice heads Meredith Kotler and Mary Eaton. They work in tandem with Boris Feldman, who also leads the firm’s global TMT practice, and up-and-coming partner Doru Gavril, both based in Silicon Valley. The practice, which continues to expand at associate level, now acts for known numerous global companies in high-stakes securities and shareholder matters, as well as regulatory investigations. A prime example is the work Feldman and Gavril are doing for Google’s parent company, Alphabet, in multiple matters including its first securities class action. Kotler’s work for 3M is equally impressive- she obtained a string of victories in cases arising from the company’s alleged failure to adequately reserve for and disclose billions of dollars of potential liability for environmental, mass tort, and other claims.